Rein Therapeutics, Inc. (RNTX) Free cash flow 2016–2022
Rein Therapeutics, Inc. (RNTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$25.0MFY2022 · since FY2016: -$15.1M → -$25.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$25.0M | -5.3% |
| FY2021 | -$23.8M | -15.2% |
| FY2020 | -$20.6M | +33.2% |
| FY2019 | -$30.9M | -10.1% |
| FY2018 | -$28.1M | — |
| FY2016 | -$15.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice